Form 4 for TNDM TANDEM DIABETES CARE INC
Accepted 2022-06-10 00:00:00 ET · period of report 2022-06-08 · accession 0001438133-22-000159 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-06-10 | 2022-06-08 | TNDM | BERGER DAVID B | EVP, COO | S - Sale+OE | $65.02 | -10.1K | 2,457 | -80% | -$656.5K |
| D | 2022-06-10 | 2022-06-08 | TNDM | BERGER DAVID B | EVP, COO | M - OptEx | $18.86 | +7,000 | 12.6K | +126% | +$132.0K |
| D | 2022-06-10 | 2022-06-08 | TNDM | BERGER DAVID B | EVP, COO | M - OptEx | $18.86 | +7,000 | 35.0K | +25% | +$132.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-08 | S | D | 7,000 | $65.03 | 5,554 | D | — | — | (F1) The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $65.00 to $65.10. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. |
| 2 | Common | Common Stock | 2022-06-08 | S | D | 3,097 | $65.00 | 2,457 | D | — | — | |
| 3 | Common | Common Stock | 2022-06-08 | M | A | 7,000 | $18.86 | 12,554 | D | — | — | |
| 4 | Derivative | Stock Option | 2022-06-08 | M | A | 7,000 | $18.86 | 35,000 | D | $18.86 · — to — | 7,000 Common Stock | (F3) The options granted on 6/14/2018 vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan ("the 2013 Plan"). (F4) The expiration date for these options is 10 years from the date of grant. |